Induction of MHC Class I HLA-A2 promoter by dengue virus occurs at the NFκB binding domains of the Class I Regulatory Complex

Virus Research

Volumn 163, Issue 1, 2012, Pages 238-245

  Othman, Shatrah ^a   Rahman, Noorsaadah Abd ^a   Yusof, Rohana ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Dengue virus; Flavivirus; HLA A2 gene; MHC Class I; Promoter

Indexed keywords

HLA A2 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA;

ARTICLE; DENGUE; DENGUE VIRUS; DNA PROTEIN COMPLEX; ELECTROPHORETIC MOBILITY; FLAVIVIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIVER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SEROTYPE; UPREGULATION;

DENGUE VIRUS; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION PROFILING; HEP G2 CELLS; HEPATOCYTES; HLA-A2 ANTIGEN; HUMANS; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTIONAL ACTIVATION;

DENGUE VIRUS; FLAVIVIRUS;

EID: 84855568156     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.09.040     Document Type: Article

References (40)

1. An J., Zhou D.-S., Zhang J.-L., Morida H., Wang J.-L., Yasui K. Dengue-specific CD8+ T cells have both protective and pathogenic roles in dengue virus infection. Immunology Letters 2004, 95(2):167-174.
2. Arnold S.J., Osvath S.R., Hall R.A., King N.J.C., Sedger L.M. Regulation of antigen processing and antigen presentation molecules in West Nile virus-infected human skin fibroblasts. Virology 2004, 324:286-296.
3. Blair G.E., Pringle C.R., Maudsley D.J. Modulation of MHC Antigen Expression and Disease 1995, Cambridge University Press.
4. Chambers T.J., Diamond M.S., Maramorosch K., Frederick A., Murphy A.J., Thomas J.C., Thomas P.M. Pathogenesis of flavivirus encephalitis. Advances in Virus Research 2003, 60:273-342.
5. Cheng Y., King N.J., Kesson A.M. Major histocompatibility complex class I (MHC-I) induction by West Nile virus: involvement of 2 signaling pathways in MHC-I up-regulation. Journal of Infectious Diseases 2004, 189(4):658-668.
6. Cheng Y., King N.J.C., Kesson A.M. The role of tumor necrosis factor in modulating responses of murine embryo fibroblasts by flavivirus, West Nile. Virology 2004, 329(2):361-370.
7. Chiewsilp P., Scott R.M., Bhamarapravati N. Histocompatibility antigens and dengue hemorrhagic fever. American Journal of Tropical Medicine and Hygiene 1981, 30(5):1100-1105.
8. Chingsuwanrote P., Suksanpaisan L., Smith D.R. Adaptation of the plaque assay methodology for dengue virus infected HepG2 cells. Journal of Virological Methods 2004, 116(2):119-121.
9. Choi S.Y., van de Mark K., Faller D.V. Identification of a cis-acting element in the class I major histocompatibility complex gene promoter responsive to activation by retroviral sequences. Journal of Virology 1997, 71(2):965-970.
10. Coffey L.L., Mertens E., Brehin A.-C., Fernandez-Garcia M.D., Amara A., Després P., Sakuntabhai A. Human genetic determinants of dengue virus susceptibility. Microbes and Infection 2009, 11(2):143-156.
11. Diamond M.S., Harris E. Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. Virology 2001, 289:297-311.
12. Douglas M.W., Kesson A.M., King N.J. CTL recognition of west Nile virus-infected fibroblasts is cell cycle dependent and is associated with virus-induced increases in class I MHC antigen expression. Immunology 1994, 82(4):561-570.
13. Drew P.D., Lonergan M., Goldstein M.E., Lampson L.A., Ozato K., McFarlin D.E. Regulation of MHC class I and beta 2-microglobulin gene expression in human neuronal cells. Factor binding to conserved cis-acting regulatory sequences correlates with expression of the genes. Journal of Immunology 1993, 150(8):3300-3310.
14. Gubler D.J. Dengue and dengue haemorrhagic fever. Clinical Microbiology Reviews 1998, 11:480-496.
15. Guitart A., Riezu-Boj J.-I., Elizalde E., Larrea E., Berasain C., Aldabe R., Civeira M.P., Prieto J. Hepatitis C virus infection of primary tupaia hepatocytes leads to selection of quasispecies variants, induction of interferon-stimulated genes and NF-κB nuclear translocation. Journal of General Virology 2005, 86(11):3065-3074.
16. Hershkovitz O., Zilka A., Bar-Ilan A., Abutbul S., Davidson A., Mazzon M., Kummerer B.M., Monsoengo A., Jacobs M., Porgador A. Dengue virus replicon expressing the nonstructural proteins suffices to enhance membrane expression of HLA class I and inhibit lysis by human NK cells. Journal of Virology 2008, 82(15):7666-7676.
17. Herzer K., Falk C.S., Encke J., Eichhorst S.T., Ulsenheimer A., Seliger B., Krammer P.H. Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity. Journal of Virology 2003, 77(15):8299-8309.
18. Holman D.H., Wang D., Raviprakash K., Raja N.u., Luo M., Zhang J., Porter K.R., Dong J.Y. Two complex, adenovirus-based vaccines that together induce immune responses to all four dengue virus serotypes. Clinical and Vaccine Immunology: CVI 2007, 14:182-189.
19. Kesson A.M., Cheng Y., King N.J. Regulation of immune recognition molecules by flavivirus, West Nile. Viral Immunology 2002, 15(2):273-283.
20. Kesson A.M., King N.J. Transcriptional regulation of major histocompatibility complex class I by flavivirus West Nile is dependent on NF-kappaB activation. Journal of Infectious Diseases 2001, 184(8):947-954.
21. King N.J., Getts D.R., Getts M.T., Rana S., Shrestha B., Kesson A.M. Immunopathology of flavivirus infections. Immunology and Cell Biology 2007, 85(1):33-42.
22. King N.J., Shrestha B., Kesson A.M. Immune modulation by flaviviruses. Advances in Virus Research 2003, 60:121-155.
23. Koller B.H., Orr H.T. Cloning and complete sequence of an HLA-A2 gene: analysis of two HLA-A alleles at the nucleotide level. Journal of Immunology 1985, 134(4):2727-2733.
24. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25(4):402-408.
25. Lobigs M., Müllbacher A., Lee E. Evidence that a mechanism for efficient flavivirus budding upregulates MHC class I. Immunology and Cell Biology 2004, 82(2):184-188.
26. Lobigs M., Mullbacher A., Regner M. MHC class I up-regulation by flaviviruses: immune interaction with unknown advantage to host or pathogen. Immunology and Cell Biology 2003, 81(3):217-223.
27. Momburg F., Mullbacher A., Lobigs M. Modulation of transporter associated with antigen processing (TAP)-mediated peptide import into the endoplasmic reticulum by Flavivirus infection. Journal of Virology 2001, 75(12):5663-5671.
28. Monath T.P. Yellow fever. Medicine 2005, 33(7):21-23.
29. Othman S., Rahman N.A., Yusof R. All serotypes of dengue virus induce HLA-A2 major histocompatibility complex class I promoter activity in human liver cells. Transactions of the Royal Society of Tropical Medicine and Hygiene 2010, 104(12):806-808.
30. Rahman N.A., Hadinur, Muliawan S., Rashid N., Muhamad M., Yusof R. Studies of Quercus lucitanica extracts on DenV-2 replication. Dengue Bulletin 2006, 30:260-269.
31. Rothman A.L. Dengue: defining protective versus pathologic immunity. Journal of Clinical Investigation 2004, 113(7):946-951.
32. Rothman A.L., Fennis F.A. Immunopathogenesis of dengue haemorrhagic fever. Virology 1999, 257:1-6.
33. Schaaf M.J.M., Willetts L., Hayes B.P., Maschera B., Stylianou E., Farrow S.N. The relationship between intranuclear mobility of the NF-kB subunit p65 and its DNA binding affinity. Journal of Biological Chemistry 2006, 281(31):22409-22420.
34. Seneviratne S.L., Malavige G.N., de Silva H.J. Pathogenesis of liver involvement during dengue viral infections. Transactions of the Royal Society of Tropical Medicine and Hygiene 2006, 100(7):608-614.
35. Shen J., T-To S.S., Schrieber L., King N.J. Early E-selectin, VCAM-1, ICAM-1, and late major histocompatibility complex antigen induction on human endothelial cells by flavivirus and comodulation of adhesion molecule expression by immune cytokines. Journal of Virology 1997, 71(12):9323-9332.
36. Shirayoshi Y., Miyazaki J., Burke P.A., Hamada K., Appella E., Ozato K. Binding of multiple nuclear factors to the 5' upstream regulatory element of the murine major histocompatibility class I gene. Molecular and Cellular Biology 1987, 7(12):4542-4548.
37. Stephens H.A., Klaythong R., Sirikong M., Vaughn D.W., Green S., Kalayanarooj S., Endy T.P., Libraty D.H., Nisalak A., Innis B.L., Rothman A.L., Ennis F.A., Chandanayingyong D. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 2002, 60(4):309-318.
38. Umareddy I., Tang K.F., Vasudevan S.G., Devi S., Hibberd M.L., Gu F. Dengue virus regulates type I interferon signalling in a strain-dependent manner in human cell lines. Journal of General Virology 2008, 89(12):3052-3062.
39. WHO, 2009. Fact Sheet No. 117, Dengue and Dengue Haemorrhagic Fever, Revised March 2009.
40. Yin-Ling L., Ching-Chuan L., Huan-Yao L., Trai-Ming Y., Yee-Shin L., Robert Mao-Yuam C., Hsiao-Sheng L. Infection of five human liver cell lines by dengue-2 virus. Journal of Medical Virology 2000, 60(4):425-431.